Presentation TCT 2025 TCT 244: Biodegradable Coronary Stent Presenter: Ryan Bruni October 28, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials Presenter: Yousif Ahmad October 28, 2025 More slides + Presentation TCT 2025 TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial Presenter: Mohammed Ali October 28, 2025 Presentation TCT 2025 TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial Presenter: Claudio Laudani October 28, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials Presenter: Yousif Ahmad October 28, 2025
Presentation TCT 2025 TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial Presenter: Mohammed Ali October 28, 2025
Presentation TCT 2025 TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial Presenter: Claudio Laudani October 28, 2025